AXGN Q2 2025 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$57M+18.3% YoY

Gross Profit

$42M74.2% margin

Operating Income

$2M3.0% margin

Net Income

$579,0001.0% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+16.7%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$7M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$205M

Total Liabilities

$93M

Stockholders' Equity

$112M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$48M	+18.3%
Gross Profit	$42M	$35M	+18.9%
Operating Income	$2M	-$428,000	+490.7%
Net Income	$579,000	-$2M	+130.1%